Logo

• Open rare cancer (KGOG4007)

  Effective drug therapy for recurrent ovarian clear cell carcinoma

  • Registration Date / Last Update Posted 2023-03-14 / 2023-07-04
  • Current Enrollment / Estimated Enrollment 75 person / 100 person (75.0%)

• Open gynecological cancer (KGOG4010)

  Assessment of quality of life after low anterior resection or viseral peritoneal stripping during cytoreductive surgery for advanced ovarian cancer requiring tumor resection on the rectosigmoid colon: a prospective cohort study

  • PI / PI기관 Hee Seung Kim /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-02-14
  • Current Enrollment / Estimated Enrollment 32 person / 108 person (30.0%)

• Open gynecological cancer (KGOG4012)

  Practice patterns and attitude towards palliative care in Korean gynecologic oncologists

  • PI / PI기관 Ga Won Yim /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-03-28
  • Current Enrollment / Estimated Enrollment person / 0 person (%)

• Open gynecological cancer (KGOG1048)

  Prediction model for survival and recurrence in early-stage cervical cancer patients with radical trachelectomy: A Multi-center Cohort Study (Korean Radical Trachelectomy of CX CA Assessment Study)

  • PI / PI기관 Dae-Yeon Kim /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 306 person / 400 person (77.0%)

• Open gynecological cancer (KGOG2015S)

  Prediction of final pathology depending on preoperative myometrial invasion and grade assessment in women with low risk endometrial cancer: a KGOG2015 ancillary study

  • PI / PI기관 Banghyun Lee /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-03-28
  • Current Enrollment / Estimated Enrollment person / 0 person (0.0%)

• Open gynecological cancer (KGOG2033)

  Comparison of various progestin treatments in patients with atypical endometrial hyperplasia ? multicenter retrospective study (CoPIA)

  • PI / PI기관 Kidong Kim /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 102 person / 500 person (20.4%)

• Open gynecological cancer (KGOG2034)

  Pelvic and Para-aortic Lymphadenectomy in Patients with Stage I or II Endometrial Cancer with High Risk of Recurrence

  • PI / PI기관 Jae Won Kim /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-02-14
  • Current Enrollment / Estimated Enrollment 425 person / 640 person (66.0%)

• Open gynecological cancer (KGOG3063)

  A Randomized Study of Paclitaxel ? Carboplatin followed by maintenance Niraparib compared to Paclitaxel ? Carboplatin ? Bevacizumab followed by maintenance Niraparib + Bevacizumab in Patients With Advanced Ovarian Cancer Following a Front-Line Complete Cytoreductive Surgery

  • PI / PI기관 Myung Cheol Lim /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-02-14
  • Current Enrollment / Estimated Enrollment person / 390 person (%)

• Open lymphoma/blood cancer (KGOG3064)

  Prospective Multi-institutional Phase III Trial of Salvage Systemic Therapy with or without Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer

  • Registration Date / Last Update Posted 2023-03-14 / 2023-07-04
  • Current Enrollment / Estimated Enrollment 26 person / 270 person (10.0%)

• Open gynecological cancer (KGOG3065)

  Oregovomab and non-platinum chemotherapy in PARP inhibitor Resistant Ovarian, Fallopian tube, or Primary peritoneal cancer patients Not candidate for Platinum Retreatment: A multicenter, two-cohort, single-arm phase 2 trial

  • PI / PI기관 Jung Yun Lee /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-02-14
  • Current Enrollment / Estimated Enrollment 30 person / 56 person (54.0%)

* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.